Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunosetm FLU, in the Second Clinical Study
STOCKHOLM, May 18. 2018 /PRNewswire/ -- This week, dosing was completed according to plan in the second clinical study with Immunosetm FLU, developed with the aim to become a modern and effective nasal influenza vaccine.
- In the perspective of this year's severe influenza outburst we are pleased to have chosen the broader quadrivalent, rather than trivalent, vaccine for our product candidate, says Dr. Anna-Karin Maltais, Chief Scientific Officer.
-The elderly always suffer most from influenza disease and we believe that we can offer a better and more convenient vaccine in this segment. This, without loosing sight of our vision, to offer the first nasal influenza vaccine for children younger than 2 years, adds Hans Arwidsson, CEO of Eurocine Vaccines.
The strategy behind this present study, and its design, was presented in a previous news release dated February 7th, 2018 and can be read at;
Mundipharma and Vectura will now progress development of the reformulation of flutiform® (fluticasone propionate/formoterol fumarate) following long-term collaboration, planning and lab-scale development work. The reformulation will ultimately ensure...
Caranx Medical (?Caranx'), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the successful world first...
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today...
NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, announces the latest innovation in the pet supplement realm: Breed Specific Soft Chews®. This new comprehensive line is made up of five products that...
Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse. This strategic collaboration is set to be significant, as it boots the range of cosmetic...
